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Abstract
The vast majority of patients with Nijmegen Breakage Syndrome (NBS) are of Slavic origin
and carry a deleterious deletion (c.657del5; rs587776650) in the NBN gene on chromosome
8q21. This mutation is essentially confined to Slavic populations and may thus be consid-
ered a Slavic founder mutation. Notably, not a single parenthood of a homozygous
c.657del5 carrier has been reported to date, while heterozygous carriers do reproduce but
have an increased cancer risk. These observations seem to conflict with the considerable
carrier frequency of c.657del5 of 0.5% to 1% as observed in different Slavic populations
because deleterious mutations would be eliminated quite rapidly by purifying selection.
Therefore, we propose that heterozygous c.657del5 carriers have increased reproductive
success, i.e., that the mutation confers heterozygote advantage. In fact, in our cohort study
of the reproductive history of 24 NBS pedigrees from the Czech Republic, we observed that
female carriers gave birth to more children on average than female non-carriers, while no
such reproductive differences were observed for males. We also estimate that c.657del5
likely occurred less than 300 generations ago, thus supporting the view that the original
mutation predated the historic split and subsequent spread of the ‘Slavic people’. We sur-
mise that the higher fertility of female c.657del5 carriers reflects a lower miscarriage rate in
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these women, thereby reflecting the role of the NBN gene product, nibrin, in the repair of
DNA double strand breaks and their processing in immune gene rearrangements, telomere
maintenance, and meiotic recombination, akin to the previously described role of the DNA
repair genes BRCA1 and BRCA2.
Introduction
Nijmegen Breakage Syndrome (NBS [MIM: 251260]) is a chromosome instability disorder
characterized by microcephaly, growth retardation, immunodeficiency, hypersensitivity to X-
irradiation, and an exceptionally high risk for lymphoid malignancy [1–3]. The NBN gene
(also abbreviated NBS, NBS1,ATV, or AT-V1, amongst others) was identified as the cause of
NBS in 1998 [4–6] and is located on chromosome 8q21 (GRCh38.p2: 89,933,336–89,984,733).
The corresponding gene product, nibrin, is part of the trimeric MRE11/RAD50 complex that
is involved in the repair of DNA double strand breaks (DSBs) and in their processing in
immune gene rearrangements, telomere maintenance, and meiotic recombination (summa-
rized in [7, 8]). This multi-functionality explains the complex NBS phenotype, particularly the
very high incidence of malignancies that form the major cause of early death amongst NBS
patients [2]. The majority of NBS patients originates from Eastern Europe and is homozygous
for a common founder mutation in the NBN gene, namely a deletion of nucleotide positions
657 to 661 of the coding sequence in exon 6 (abbreviated as c.657del5; rs587776650) that leads
to two truncated fragments, p26- and p70 nibrin [9].
To the best of our knowledge, NBN c.657del5 is the only Slavic founder mutation of high
prevalence described so far. It obviously predated the medieval migration of the Slavic tribes.
Until recently, our insights into the history of the Slavs, the largest population in Eastern and
Southeastern Europe, were mainly based upon linguistic and archaeological evidence.
Although a common origin of the Slavs is generally accepted, controversy exists about their
original homeland and the timing of their historical diversification. During the early medieval
waves of migration into Europe in the 5th and 6th century, the Slavs split into the Eastern Slavs
(Belarusians, Russian, Ukrainians), the Western Slavs (e.g. Czechs, Poles, Slovaks, Sorbs), and
the Southern Slavs (e.g. Bulgarians, Croats, Serbs, Slovenes) (cited in [10, 11]). A recent study
of autosomal, mitochondrial and Y-chromosomal data coined the existence of two sub-groups
that presumably existed some 1900 years ago, namely the East-West Slavs (from Poland to the
Volga river) and the South Slavs (confined to the Balkan Peninsula) [12]. Moreover, the study
revealed pronounced genetic similarities between the Czechs and their immediate Germanic
neighbors while, further north, the Sorbs and the surrounding Germans were clearly geneti-
cally distinct [13]. However, the time of the initial division of the proto-Slavic tribes was not
determined. From the evolutionary history of Y-chromosomal STR haplotype R1a, the Russian
Plain branch (including proto-Slavic tribes) living in present-day Russia, Ukraine, Belarus,
Poland and the Baltic countries is estimated to have appeared about 4,600 years ago [14].
Interestingly, a high frequency of heterozygous c.657del5 carriers has been reported from
the Slavic populations of Poland, the Czech Republic/Slovakia (henceforth abbreviated as CS),
the Ukraine, and Germany [15, 16]. Notably, heterozygous carriers were particularly prevalent
among cancer patients in these populations (reviewed in [17, 18]), an association that was rig-
orously confirmed in a family-based study carried out with the Index-Test Method [19].
Whilst heterozygous carriers seemingly reproduce, despite their increased cancer risk, no
parenthood of a homozygous individual has been reported so far. The high frequency of
Slavic NBN Founder Mutation
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c.657del5 carriers in different Slavic populations therefore seems enigmatic and difficult to
explain by genetic drift alone. This can readily be illustrated by a simple selection model with
relative fitness values of 1-hs and 1-s for hetero- and homozygous mutation carriers [20].
Assuming s>0.9 and an initial mutation frequency of 0.1%, the latter is expected to decrease
slightly (to ~0.085%), rather than increase, within 200 generations if h = 0. Moreover, the
mutation frequency is bound to fall below 10−11 over the same time period if h = 0.1, i.e. if het-
erozygous carriers are of slightly reduced reproductive fitness (data not shown).
In the present study, we provide evidence from a family-based cohort study for a reproduc-
tive advantage of female heterozygous c.657del5 carriers that potentially explains the high fre-
quency of this mutation in Eastern Europe by balancing selection. In addition, we estimated
c.657del5 to be approximately 4000 to 6650 years old, using a large collection from unrelated
carriers of Eastern, Western and Southern Slavic origin.
Materials and Methods
Reproductive success of NBN c.657del5 carriers
We assessed the relative reproductive success of heterozygous NBN c.657del5 carriers relative
to their non-carrier relatives. To this end, we drew upon a large collection of families of NBS
patients from the Czech Republic and Slovakia that were originally recruited as part of a study
to assess the relative cancer risk of carriers and non-carriers [19]. For more than 20 years, one
of us (E.S.) has seen virtually all patients with clinically confirmed NBS in these countries. The
present study, more specifically, includes 24 families with 344 members for whom comprehen-
sive medical records were available to us. Seven of these families had been counseled and
repeatedly interviewed over 10–20 years whilst another seven were regularly contacted for
over 20–25 years. The remaining 10 families were diagnosed and followed between 1994 and
2003. Molecular testing after 1998 confirmed that all NBS cases were homozygous for the NBN
c.657del5 mutation.
Starting from the affected child in each pedigree (‘index patient’), as many relatives as possi-
ble were contacted through the parents of the index patient. Attempts were made to contact all
grandparents, their siblings (if alive), aunts, uncles and cousins who lived in the Czech Repub-
lic. Relatives were recruited without prior knowledge of their c.657del5 carrier status. Of the
490 individuals contacted, 344 agreed to participate in our study.
Upon informed consent, oral interviews were conducted via structured questionnaires
administered by one and the same person (E.S.). The questionnaires covered socio-demo-
graphics (including reproductive history), general medical history, life style and occupational
history. Socioeconomic status was inferred from the educational level attained when leaving
school. Family history and gynecological as well as obstetric history were recorded for female
participants only. The vast majority of interviews took place at the homes of participants and
required around 60 minutes each. Obligate heterozygotes were not included so that the inter-
viewer was consistently ‘blinded’ with respect to the carrier status of their interviewees. After
the interview, a blood sample was taken to assess the NBN germline mutation c.657del5 geno-
type [21].
We compared the number of offspring of c.657del5 carriers and non-carriers, separately for
males and females. Statistical analyses were carried out with Fisher´s exact or an unpaired t-
test, as appropriate.
Age estimation for NBN c.657del5
Sampling of individuals. We used the family data available to us to reconstruct the origi-
nal NBN c.657del5 haplotype and to estimate the age of the deletion. In addition, we analyzed
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Guthrie cards from newborn screening programs:, including 1502 samples from Bulgaria, 994
from Croatia, and 1035 from Lusatia (Germany), the latter being part of an extensively pheno-
typed sample from Eastern Germany [13]. We also asked colleagues for additional samples
from NBS patients of Eastern, Western, and Southern Slavic origin (Table 1).
Genotyping and reconstruction of haplotypes. Some 84 homozygous and 19 heterozy-
gous NBN c.657del5 carriers were genotyped at markers covering a 5.7 Mb region around the
deletion on chromosome 8q21. More specifically, 13 microsatellites located between D8S271
and D8S270 were analyzed (Table 2) in addition to 12 SNPs (Table 3). For 187 chromosomes
carrying NBN c.657del5 (S1 File), 92 haplotypes could be deduced without ambiguity using the
available family data (Table 1). These haplotypes formed the basis of our attempt to estimate
the age of the mutation. The unambiguous haplotypes and the most likely albeit ambiguous
haplotypes are listed in the Supporting Information (S1 File).
Genetic marker distances. We considered two commonly used genetic maps, namely the
Rutgers map [22–25] and the high-resolution recombination map from deCODE Genetics
[26]. We abstained from involving the genetic map provided by the Marshfield Clinic [27]
because it does not resolve large parts of the investigated chromosomal region. Where possible,
we used sex-averaged maps. If the available map information did not include genetic distances
for particular markers, as was the case for some microsatellites and all SNPs, these distance
were interpolated assuming proportionality between physical and genetic distance, and by
drawing upon the closest marker of known genetic location on either side of an uncharted
marker. Since each marker had to be assigned a unique location for the age estimation software
to function properly (see below), we introduced an artificial genetic distance of 10−9 cM
between adjacent markers if they had the same genetic location according to the map in ques-
tion (Table 2).
Age estimation. We used the DMLE+ software [28] for estimating the age of NBN
c.657del5. This software employs a Bayesian algorithm to infer the location and/or age of a
founder mutation based upon patterns of linkage disequilibrium and associated demographic
parameters [29]. Numerical integration in DMLE+ is done by Monte Carlo Markov Chain
Table 1. Individuals and haplotypes used for the c.657del5 age estimation and ancestral haplotype inference.
Origin Sampled individuals
(heteroz.)
c.657del5 carrying
chromos.
Unambiguously inferred c.657del5 carrying
haplotypes
Austria 1 (1) 1 0
Belgium 1 2 0
Bulgaria 4 (4) 4 0
Czech Republic/Slovakia
(CS)
9 (1) 17 11
Croatia 1 2 2
Germany (Germans) 22 (2) 42 4
Germany (Sorbs from
Lusatia)
10 (10) 10 3
Italy 1 2 2
Poland 35 70 64
Russia 10 (1) 19 0
Turkey 3 6 6
Ukraine 6 12 0
Total 103 (19) 187 92
Haplotypes were inferred from both homo- and heterozygous deletion carriers.
doi:10.1371/journal.pone.0167984.t001
Slavic NBN Founder Mutation
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(MCMC). Note that this software does not estimate the time to the most recent common
ancestor (MRCA), but the actual age of the mutation. We initially used DMLE+ assuming a
known location of the mutation (Table 2) together with the following parameters: population
growth rate 0.01, mutation population frequency 1.0 (since all haplotypes carried the
Table 2. Microsatellite markers and one InDel polymorphism used in this study.
Marker Available alleles Sample heterozygosity Physical distance [kb] Genetic map [cM]
Rutgers Decode
D8S271 89 0.614 0 0 0
D8S273 85 0.494 393.2 0.0000000001 0.0000000001
rs6150693‡ 84 0.023 1,020.1 0.6485 0.453
D8S1800 91 0.423 1,176.7 0.7300 0.5100
AFM289 87 0.130 1,586.4 0.8152 0.6662
H3GT 89 0.189 1,947.2 0.8903 0.8038
H2CA 89 0.209 2,307.9 0.9653 0.9414
D8S88 92 0.257 2,330.6 0.9700 0.9500
NBN c.657del5 92 0.000 2,440.2 1.1128 1.0357
H5CA 82 0.137 2,602.0 1.3235 1.1621
D8S1811 91 0.146 2,714.5 1.4700 1.2500
D8S1724 92 0.181 2,901.6 1.4700000001 1.5700
D8S1146 82 0.181 3,504.9 1.8017 1.7019
D8S1618 85 0.134 3,986.7 2.0665 1.8073
D8S270 86 0.716 4,502.3 2.35 1.92
All markers are located on chromosome 8q21. Physical distances according to human genome assembly hg19 (Genome Reference Consortium GRCh37).
‡Note that the InDel polymorphism rs6150693 (position 89607483), which affects 12 base-pairs, has been removed from dbSNP on Oct 17, 2013, due to
mapping or clustering errors (http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?type=rs&rs=rs6150693), but is listed in UCSC’s Genome Browser (http://
genome.ucsc.edu/).
doi:10.1371/journal.pone.0167984.t002
Table 3. Additional single-nucleotide polymorphism markers at the 92 unambiguously inferred haplotypes in this study.
Marker Available alleles Allele on haplotype Global MAF Physical distance [kb] Genetic map [cM]
Rutgers Decode
rs10111232 90 C 0.0004 2,394.3 1.0529 0.9998
rs1063045 92 T 0.3792 2,429.3 1.0986 1.0272
rs1805794 92 G 0.3570 2,437.4 1.1092 1.0335
NBN c.657del5 (rs587776650) 92 c.657del5 - 2,440.2 1.1128 1.0357
rs2234744 92 T 0.3530 2,449.5 1.1249 1.0430
rs709816 92 T 0.3914 2,452.7 1.1291 1.0455
rs1061302 92 C 0.3528 2,465.3 1.1455 1.0553
rs3736639 92 A 0.3792 2,472.3 1.1546 1.0607
rs1063053 92 T 0.3219 2,476.8 1.1605 1.0643
rs13272541 92 C <0.0002 2,493.4 1.1821 1.0772
rs1000249 86 A <0.0002 2,554.3 1.2614 1.1248
rs6994202 86 A 0.2899 2,577.8 1.2920 1.1432
rs11994308 86 C 0.0899 3,142.2 1.6022 1.6226
All markers are located on chromosome 8q21. Physical distances according to human genome assembly hg19 (Genome Reference Consortium GRCh37).
All SNPs were found to be monomorphic in our sample. MAF: minor allele frequency, obtained from dbSNP (http://www.ncbi.nlm.nih.gov/snp).
doi:10.1371/journal.pone.0167984.t003
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mutation); burn-in iteration 5,000,000; data iterations 10,000,000; number of histogram bars
200; mutation age limits 0–5000 generations; no star-like genealogy; no sequence weights. Sub-
sequently, we considered population growth rates of 0.005 and 0.001 as well in order to assess
the effect of this parameter on the age estimate. The R statistical software [30], version 3.2.2,
was used for descriptive statistics and for creating graphs. Perl was used for scripting the analy-
sis with DMLE+.
Our study was approved by the Ethics Committee of the 2nd Medical School of Charles Uni-
versity and University Hospital Motol, Prague, Czech Republic. All participants gave signed
informed consent, with the exception of the Sorb probands [13]. The respective study was
approved by the Ethics Committee of the Leipzig University, Germany, and all participants
had given their signed informed consent.
Results
Reproductive success of NBN c.657del5 carriers
The reproductive success of female NBN c.657del5 carriers was compared to that of their non-
carrier relatives in a cohort of 40 heterozygotes and 208 homozygotes for the wild-type allele.
The average age was almost the same in the two groups (51.2 vs. 50.9 years, respectively). How-
ever, the average number of offspring differed significantly (P = 0.02), with 3.03 children born
by carriers and 2.36 children born by non-carriers (Table 4). For an age-stratified analysis, we
split the cohort into three age groups: <40 years, 41–60 years, and>60 years at the time of the
last interview. In all three groups, carriers had more children on average than non-carriers,
and this difference was statistically significant in the 41–60 years age group (Table 4). There
was no statistically significant difference with respect to school and university attendance
between carriers and non-carriers. Furthermore, we also compared the menstrual history of
female carriers and non-carriers, characterized by the age at first menstrual period and the age
at onset of menopause (females 30 years and older). We observed no significant difference
between the two groups in this regard (data not shown). No significant difference in the num-
ber of offspring was observed between male mutation carriers and non-carriers (Table 5). Data
on survival until reproductive age were not available to us.
The number of spontaneous or induced abortions could be ascertained for 32 of the 40
female carriers and for 145 of the 208 female non-carriers, with both subgroups being of
almost the same average age (54.5 and 53.4 years). The relative number of induced abortions
was virtually the same whilst the rate of spontaneous abortions was slightly albeit non-signifi-
cantly lower among carriers (Table 6). The 48 obligate heterozygous females (not included in
the above analysis) had 57 living offspring (30 affected by NBS), three fetuses diagnosed with
NBS, and 11 pregnancies that were interrupted for other reasons. Two fetuses were lost sponta-
neously. Of 73 registered pregnancies, only two thus ended spontaneously.
Table 4. Number of offspring of female NBN c.657del5 carriers and non-carriers of different age groups.
Age group Carriers of c.657del5 Non-carriers of c.657del5 P
N Average age Number of offspring Ratio N Average age Number of offspring Ratio
<41 12 32.3 21 1.75 77 32.2 123 1.60 0.59
41–60 17 51.6 62 3.65 61 51.3 160 2.62 0.01
>60 11 71.2 38 3.45 70 71.0 207 2.96 0.47
All groups 40 51.2 121 3.03 208 50.9 490 2.36 0.02
Average age is given in years. The two-tailed P-values were obtained from unpaired t-test.
doi:10.1371/journal.pone.0167984.t004
Slavic NBN Founder Mutation
PLOS ONE | DOI:10.1371/journal.pone.0167984 December 9, 2016 6 / 18
Age of the NBN c.657del5 mutation
We applied the DMLE+ software to a set of microsatellite markers to estimate the age of NBN
c.657del5. In order to assess the sensitivity of these analyses to the underlying assumptions, we
assumed two different genetic maps and three different population growth rates. With an aver-
age population growth of 1% per generation, the mean posterior age estimate was 265 and 267
generations, respectively, for the Rutgers and the deCODE genetic map. This would roughly
correspond to approximately 4000 to 6650 years, depending upon the presumed generation
time (15 to 25 years; Table 7). Larger estimates of 343 to 369 and 509 to 698 generations were
obtained for growth rates of 0.5% and 0.1%, respectively. These figures would correspond to
an age range of 7000 to 12,500 years, assuming a generation time of 20 years (Table 7 and
Fig 1).
Reconstruction of ancestral mutation haplotype
Of the 92 haplotypes that carried NBN c.657del5 and that could be deduced without ambiguity
(S1 File), 22 (23.9%) carried identical alleles at all markers between the two most distant micro-
satellites D8S271 (allele 257) and D8S270 (allele 200). This haplotype (Table 8) was found in
individuals from Poland, Germany, CS and Lusatia (Sorbs) and most likely represents the
ancestral haplotype. The remaining 95 haplotypes from 40 homozygous and 15 heterozygous
c.657del5 carriers (out of a total of 187 chromosomes) could not be resolved without ambiguity
and are best guesses (S1 File). Among these haplotypes, we observed the putative ancestral
haplotype not only in individuals from the countries mentioned above, but also from Bulgaria,
Russia, and the Ukraine. Some 30% of chromosomes carrying the founder mutation showed
the deduced founder haplotype (Table 8). Moreover, all 187 chromosomes carrying c.657del5
showed the same SNP alleles (Table 3). Therefore, the deletion is not only confined to individ-
uals of Slavic origin but is most likely due to a single mutational event. All differences observed
Table 5. Number of offspring of male NBN c.657del5 carriers and non-carriers of different age groups.
Age group Carriers of c.657del5 Non-carriers of c.657del5 P
N Average age Number of offspring Ratio N Average age Number of offspring Ratio
<41 20 31.5 34 1.70 62 34.9 109 1.76 0.80
41–60 21 50.7 61 2.90 66 51.3 158 2.39 0.25
>60 18 70.1 51 2.83 40 71.2 99 2.48 0.45
All groups 59 50.1 146 2.47 168 50.0 366 2.18 0.20
Average age is given in years. The two-tailed P-values were obtained from unpaired t-test.
doi:10.1371/journal.pone.0167984.t005
Table 6. Reproductive histories for the subset of female NBN c.657del5 carriers and non-carriers who were older than 30 years, ascertained by the
index test method and had information on the number of spontaneous or induced abortions available.
Carriers of c.657del5 Non-carriers of c.657del5 P
Number of mothers 32 145
Average age (years) 54.5 53.4
All registered pregnancies 120 436
Number of living offspring (proportion of all pregnancies) 102 (85.0%) 351 (80.5%) 0.46
Number of spontaneous abortions (proportion of all pregnancies) 7 (5.8%) 41 (9.4%)
Number of induced abortions (proportion of all pregnancies) 11 (9.2%) 44 (10.1%)
The two-tailed P-values were obtained from Fisher´s exact test.
doi:10.1371/journal.pone.0167984.t006
Slavic NBN Founder Mutation
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Table 7. Age estimates for the NBN c.657del5 deletion.
Years per generation Mean (95% credible interval)
Rutgers map Decode map
Assumed population growth of 1.0%
Generations 264.8 (149.5–512.4) 267.2 (143.9–475.5)
Years 15 3972.0 (2241.8–7686.1) 4008.0 (2158.5–7131.8)
20 5296.0 (2989.1–10,248.2) 5344.0 (2878.1–9509.1)
25 6620.0 (3736.4–12,810.2) 6680.0 (3597.6–11,886.4)
Assumed population growth of 0.5%
Generations 369.1 (186.4–702.0) 343.0 (185.4–759.2)
Years 15 5536.5 (2796.3–10,530.2) 5145.0 (2781.3–11,387.7)
20 7382.0 (3728.4–14,040) 6860.0 (3708.4–15,183.6)
25 9227.5 (4660.5–17,550.4) 8575.0 (4635.5–18,979.6)
Assumed population growth of 0.1%
Generations 508.8 (166.9–1470.8) 698.0 (185.3–2261.6)
Years 15 7632.0 (2504.0–22,062.0) 10,470.0 (2779.3–33,924.3)
20 10,176.0 (3338.6–29,416.0) 13,960.0 (3705.7–45,232.4)
25 12,720 (4173.3–36,770.0) 17,450.0 (4632.1–56,540.5)
doi:10.1371/journal.pone.0167984.t007
Fig 1. Posterior distribution of age estimates for NBN c.657del5. Box plots of the posterior age distribution refer to a population growth of 1.0%, 0.5%
and 0.1%, respectively, and two genetic maps.
doi:10.1371/journal.pone.0167984.g001
Slavic NBN Founder Mutation
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for individual microsatellite alleles are explicable by past recombination or mutation owing to
the non-negligible recombination rate between the STR markers (Table 2) and the high muta-
tion rates of microsatellites of 10−4 to 10−2 per generation.
We next aimed at inferring likely recombination events using an ad-hoc approach that pos-
tulated a recombination if two or more adjacent markers in the flanking regions of the original
haplotype differed from the putative ancestral alleles. Using this approach, we identified more
than 50 likely recombination events, most of them representing single events (Table 8). A rare
deletion polymorphism was documented in one chromosome from Germany (255-158-del-
139 at D8S271-D8S273-rs6150693-D8S1800) and one chromosome from Austria (255-
156-del-139 at D8S271-D8S273-rs6150693-D8S1800) as well as in one Polish individual (267-
160-del-145 at D8S271-D8S273-rs6150693-D8S1800). The flanking microsatellites on two
chromosomes from Turkey shared the same alleles (261 at D8S271, 194 at D8S270) that were
different from the original alleles (257 at D8S271, 200 at D8S270), rendering a common origin
of the respective disease mutations rather likely.
Discussion
We estimated the age of the NBN c.657del5 founder mutation and sought for an explanation of
its widespread occurrence in Slavic populations. Our calculations place the original mutation
at around 266 generations ago assuming a growth rate of 1% per generation, and at around
356 generations ago with a rate of 0.5%. These estimates translate into roughly 5300 to 7100
years, given a generation time of 20 years. These estimates are consistent with a previous
assessment [14] of the age of the R1a Y-STR haplotype (4600 years), which is indicative of the
Russian Plain branch (including proto-Slavic tribes) and which is present in Russia, Ukraine,
Belarus, Poland and the Baltic countries. Furthermore, our estimates are in concordance with
the proposed time of the split between the Proto-Balto-Slavic languages and the Indo-Euro-
pean tree around 4500–7000 YBP, but would predate the proposed split between Slavic and
Baltic branches between 3500 and 2500 YBP (summarized in [12]). While this does not pre-
clude the presence of NBN c.657del5 at low frequency in the steppe Yamnaya people before
their admixture with Central and Western Europeans around 4500 YBP [46], our findings ren-
der far more likely a mutation origin in the ancestor population of all Slavic peoples, either
before or after its admixture with the Yamnaya. Unfortunately, our data do not allow formal
distinction between these two scenarios.
It should be noted that DMLE+ does not estimate the time to the most recent common
ancestor (MRCA) of extant deletion carriers, but the actual mutational age. Thus, the dele-
tion may have existed in the population at low frequency for some time before the MRCA.
As regards the underlying population growth rate, we deem 1% to be a realistic assumption.
While it is still possible that the true rate may have been closer to the (commonly used)
value of 0.5%, rates of 0.1% or less appear unrealistic in view of the massive population
expansion that took place during the late Neolithic and the Bronze Age. That different age
estimates resulted from the use of two genetic maps is explicable in terms of slightly larger
genetic distances in the Rutgers map, rendering recombination more likely and reducing
the time span required to explain an observed haplotype pattern, compared to the deCODE
map.
While the NBN c.657del5 mutation is found in all Slavic populations, a rather high hetero-
zygote frequency (0.5–1.0%) has been reported for Ukraine (Eastern Slavs), Poland, CS, and
Sorbs in Germany (Western Slavs), and for Bulgaria (Southern Slavs) (Table 9). These figures
may still represent underestimates, because all of the countries are characterized by admixture
between the Slavic and previous indigenous population. They also experienced massive
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population movement after World War II. Thus, while the heterozygote frequency was esti-
mated to be 1 in 167 (9 of 1502) in Bulgaria when based upon a random collection of Guthrie
cards, it increased notably to 1 in 111 (9 of 1002) when the analysis was confined to cards from
individuals with Slavic surnames.
Table 9. Frequency of heterozygous NBN c.657del5 deletion carriers in different populations.
Country Absolute number Relative number Allele frequency Reference
Poland
Mazowsze 10/1,620 1/162a 0.31% Steffen et al. 2004[31]
Gdansk 21/4,000 1/190a 0.26% Kanka et al. 2007[32]
Szczecin 3/530 1/176b 0.28% Gorski et al. 2003[33]
Szczecin 9/1,500 1/167a,b 0.30% Cybulski et al. 2004[34]
Malopolska 12/2,274 1/190a 0.26% Varon et al. 2000[15]
Wielkopolska 16/2,090 1/131a 0.38% Ziolkowska et al. 2006[35]
var. Voivodships 6/1,000 1/167a 0.30% Chrzanowska et al. 2006
[36]
Czech Republic
8/1,234 1/154a 0.33% Varon et al. 2000[15]
4/383 (34 y.) 1/96b 0.52% Drabek et al. 2002[37]
5/1,411 1/282b 0.18% Pardini et al. 2009[38]
2/915 1/457b 0.11% Mateju et al. 2012[39]
Ukraine
5/908 1/182a 0.28% Varon et al. 2000[15]
Belarus
Minsk 1/1,014 1/1,014 0.05% Bogdanova et al. 2008[40]
Russia
0/548 0/548c 0.09% Resnick et al. 2003[41]
2/348 (38.6 y.) 1/174b 0.29% Buslov et al. 2005[42]
0/344 (80.5 y.) 0/344b 0.15% Buslov et al. 2005[42]
Bulgaria
9/1002 1/111a 0.45% this report
Croatia
2/994 1/497a 0.10% this report
Slovakia
3/2,996 1/999a 0.05% Seemanova et al. 2004[43]
Germany
not specified 1/886 1/886b 0.06% Carlomagno et al. 1999[44]
Lusatia (Sorbs) 5/1,035 1/207b 0.24% this report
Lusatia (Sorbs) 5/170 1/34b 1.49% Maurer et al. 2010[16]
Northeast
Bavaria
6/10,656 1/176a 0.28% Maurer et al. 2010[16]
Berlin 1/990 1/990a 0.05% Maurer et al. 2010[16]
Hannover 0/1,017 0/1,017b 0.05% Bogdanova et al. 2008[40]
China
0/804 0/804b 0.06% He et al. 2012[45]
Study design:
a newborn;
b adults (average age);
c not specified.
doi:10.1371/journal.pone.0167984.t009
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The high frequency of c.657del5 carriers observed in Northeast Bavaria has been explained
by local immigration of Slavic people between the 6th and 9th century [16]. On the other hand,
the rather low heterozygote frequency in Slovakia was completely unexpected because of the
high frequency of c.657del5 homozygotes, higher than in the adjacent Czech Republic. This
discrepancy has been explained by the presence of traditional population isolates in Slovakia
and by difficulties in collecting representative samples [43].
Transmission distortion has been put forward as an explanation of the abundance of
c.657del5 (reviewed in [47]). Unfortunately, our data do not allow validation of this idea. Two
other explanations for the persistence of a deleterious mutation in a population are chance
(genetic drift) and reproductive advantage. Generally speaking, genetic drift explains well the
increase in frequency of disease-causing mutations in local populations of recent origin, but
does rather less convincingly so for a consistent trend across old and geographically separated
populations [48]. On the other hand, balancing selection, involving a heterozygote advantage
due to higher reproductive fitness, is a more likely explanation for the persistence of a deleteri-
ous founder mutation, thereby complementing the scarce evidence in humans (reviewed in
[49]).
Based upon our study of the reproductive history of individuals from the Czech Republic,
we found that female heterozygous NBN c.657del5 carriers gave birth to more children on
average than non-carriers, pointing to a higher fertility of the former. No significant differ-
ences were observed between male carriers and non-carriers. Of note, our analyses of the num-
ber of offspring and of the reproductive histories partially included individuals from the same
families. However, since we conditioned our analyses on mutation carrier status, observations
in these analyses were conditionally independent and the applied statistical tests remained
valid under the assumption of negligible intra-familial, i.e. block-like, effects other than muta-
tion carrier-ship.
Clearly, many factors influence reproductive behaviour in modern societies. In our study,
participants were interviewed before their NBN c.657del5 genotypes were known, and there-
fore the interviewer was blind to their NBN status. Moreover, the control homozygotes for the
wild-type allele came from the same families. We found no evidence for differences between
the two groups with respect to age at first menstrual period or at onset of menopause. How-
ever, we observed that the increase in offspring number was paralleled by a slight decrease in
the number of spontaneous, not induced, abortions. Interestingly, a higher birth rate and
lower spontaneous abortion frequency were also reported for female carriers of deleterious
mutations in the DNA repair genes BRCA1 und BRCA2 [50–52]. From an evolutionary point
of view, this link is explicable in terms of genetic variation in DNA repair genes that predis-
poses to cancer causing better survival under adverse environmental conditions [53].
The NBN gene is expressed in human germ cells. Immunofluorescent localisation showed
that nibrin is specifically found at meiotic telomeres [54]. In all organisms tested so far, nibrin
is required for meiotic recombination (reviewed in [55]). Moreover, it physically interacts with
BRCA1 at the centrosomes and is obviously involved in mitotic centrosome maintenance [56].
Consequently, NBS patients show an impaired development of gonads and ovarian failure in
females [2]. The analysis of a humanized NBN mouse model provides direct evidence, that the
development of male germ cells is somewhat retarded while most female oocytes are arrested
at pachytene[57].
Human female meiosis, but not male meiosis, is a highly error-prone process. Fewer than
30% of naturally fertilised human ova survive to term. The vast majority of losses occur before
clinical recognition of pregnancy [58, 59]. The leading cause of these losses is a high rate of
aneuploidies due to spontaneous non-disjunction during maternal meiosis [60–62]. Moreover,
aneuploidies are also the major cause of spontaneous abortions in humans, affecting 10 to 15%
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of all recognized pregnancies. In principle, a slightly lower rate of non-disjunction in female
carriers of the founder mutation could explain their higher fertility. Although highly specula-
tive at this point, this assertion can be tested empirically.
The unusually high rate of human maternal meiotic non-disjunction and its further
increase with age is explained by an interplay between unique features of oogenesis, i.e. recom-
bination failure, loss of cohesion between sister chromatids, and sister centromeres in combi-
nation with a relaxed spindle checkpoint [63, 64]. This anomalous chromosomal behaviour
still persists during the first mitotic divisions[65] and is paralleled by diminished mRNA levels
of several checkpoint proteins and also of cohesin (reviewed in [66]). Carriers of the NBN
c.657del5 mutation have a distinct gene expression phenotype with about the same number of
genes up- and down regulated [67]. Moreover, based upon SDS-PAGE and mass spectrometry,
it was shown that the two truncated proteins, p26 and p70, synthesized by carriers of the muta-
tion, bind to proteins that do not interact with full-length nibrin [68]. It is tempting to specu-
late that these effects are also relevant in maternal germ cells and could explain the increase in
fecundity of carriers. Thus, in future experiments, the interactors of these fragments should be
studied in oocytes of females with the carrier mutation. In our view, the humanized NBN
mouse would an ideal animal model to undertake such studies.
In summary, we presented evidence that the Slavic founder mutation NBN c.657del5,
which has been implicated in Nijmegen Breakage Syndrome and cancer, may actually confer a
reproductive advantage for female carriers due to higher fertility. Our age estimate for this
mutation of less than 300 generations for this mutation implies that such an advantage could
well explain the allele frequency of between 0.5% and 1.0% in Slavic populations.
Supporting Information
S1 File. Set of 92 haplotypes that could be inferred without ambiguity (lines 97–188) and
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